Albertsons Companies TodayACIAlbertsons Companies$12.75 +0.21 (+1.65%) As of 10/13/2026 03:59 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$10.86▼$20.00Dividend Yield5.33%P/E Ratio159.34Price Target$14.62Add to WatchlistAlbertsons Companies NYSE: ACI stock showed signs of bottoming in mid-October, rising by more than 2% following its Q2 fiscal year 2027 (FY2027) earnings report.
Executives at America's second-largest supermarket chain are in search of a turnaround as consumers spend less.
Albertsons Companies, Inc. (ACI) Q2 2026 Earnings Call Transcript
Albertsons Companies NYSE: ACI reported a 0.8% decline in second-quarter identical sales and outlined a broader turnaround effort centered on cost reductions, targeted price investments, operational simplification and a review of its portfolio of businesses and assets.
Albertsons has underperformed peers, but current valuation offers a wide margin of safety with a 6.5x P/E and double-digit earnings yield. Despite weak recent results and macro headwinds, ACI is investing in price, private label penetration, and operational efficiency to stabilize revenue and margins. Management expects near-term softness but sees potential for improvement in the second half as cost-saving initiatives and consumer trends take effect.
Evaluate the expected performance of Albertsons Companies (ACI) for the quarter ended August 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
AC Immune maintains a "Buy" rating, driven by positive 100-week safety and immunogenicity data for ACI-7104 in early-stage Parkinson's disease. Progress in the pipeline includes Takeda-partnered ACI-24 for prodromal Alzheimer's, triggering a $12M milestone and showing antibody responses at all dose levels. Brain-penetrant NLRP3 inhibitor ACI-19764 advances, with phase 1/1b initial data at the end of 2026 and final data in the 1st half of 2027, targeting neuroinflammatory and metabolic disorders.
Investors need to pay close attention to ACI stock based on the movements in the options market lately.
Albertsons named former eBay and Hewlett Packard chief Meg Whitman to the newly created post of executive chair, as the grocery-store operator grapples with falling sales and cautious consumer spending.
ACI Worldwide has agreed to acquire Cranium Ventures, a privately held developer of cloud-native card payment switching technology, as it seeks to expand its card-processing capabilities. The Omaha, Nebraska, payments technology company said Tuesday (Sept.
ACI Worldwide is rated Buy, leveraging a sticky customer base, strong margins, and a reasonable 14.6x forward P/E. Payment Software drives the investment case, with 9% segment growth and a 48% adjusted EBITDA margin, fueled by renewals, pricing, and cross-selling. Connetic provides a modernization path for legacy clients, but the current valuation does not require rapid platform adoption or a Biller sale.
The grocer said average order value is higher for online shoppers when they use AI-powered online shopping assistants, helping the company nab a small win in the tricky world of AI economics.